首頁 > 市場調查報告書 > 醫療設備

自動化

市場調查報告書

商品編碼

1634173

全球實驗室機器人市場 - 2025 - 2033

Global Laboratory Robotics Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球實驗室機器人市場規模達23.4億美元，預計2033年將達到44.0億美元，2025-2033年預測期間複合年成長率為6.4%。

實驗室機器人技術是利用自動化系統精確且有效率地執行各種實驗室任務。這些系統用於製藥、生物應用、臨床診斷和化學研究等行業。它們提高了工作流程生產力並減少了人為錯誤。自動化應用、人工智慧和機器學習的進步使得高通量分析以及與實驗室資訊系統的整合成為可能。實驗室機器人技術的採用正在改變現代實驗室，使其更有效率、可擴展，並且能夠滿足科學研究和工業應用日益成長的需求。

市場動態：

驅動程式和限制

科技進步的崛起

由於自動化技術、人工智慧和機器學習的進步，全球實驗室機器人市場正在成長。這些技術提高了精度、效率和可擴展性，使其在現代實驗室操作中至關重要。機器人現在擁有先進的感測器、資料分析功能和物聯網整合，簡化了工作流程並減少了人為錯誤。此外，機械手臂、人工智慧驅動的決策和靈活編程的進步將實驗室機器人的範圍擴展到藥物發現、基因組學和臨床診斷等領域。這些技術的發展推動了實驗室機器人技術的全球採用。

例如，2023 年 5 月，Opentrons 推出了 Opentrons Flex 機器人，這是無障礙液體處理實驗室機器人的新時代。這種創新的應用程式專為提高成本效益和易於編程而設計，旨在實現先進實驗室自動化的民主化，使其適合各種規模的人員使用，並為研究人員提供先進的自動化功能。

初始投資和維護成本高

由於初始投資和維護成本高昂，全球實驗室機器人市場面臨重大挑戰。高級應用和專用組件需要大量的前期成本，使得較小的實驗室和研究設施不太容易獲得它們。軟體相容性和基礎設施升級等整合成本增加了財務負擔。維護費用，包括維修和校準，進一步增加了總擁有成本。對熟練人員的需求進一步增加了營運費用，使得潛在的最終用戶，尤其是發展中地區的潛在最終用戶，不願投資實驗室機器人。

有關此報告的更多詳細資訊 - 索取樣本

Laboratory robotics is the use of automated systems to perform various laboratory tasks with precision and efficiency. These systems are used in industries like pharmaceuticals, bioApplication, clinical diagnostics, and chemical research. They enhance workflow productivity and reduce human error. Advancements in automation Application, artificial intelligence, and machine learning have enabled high-throughput analysis and integration with laboratory information systems. The adoption of laboratory robotics is transforming modern laboratories, making them more efficient, scalable, and capable of meeting the growing demands of scientific research and industrial applications.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

The global laboratory robotics market is growing due to advancements in automation technologies, artificial intelligence, and machine learning. These technologies improve precision, efficiency, and scalability, making them essential in modern lab operations. Robots now have advanced sensors, data analytics capabilities, and IoT integration, streamlining workflows and reducing human error. Additionally, advancements in robotic arms, AI-driven decision-making, and flexible programming expand the scope of laboratory robotics to areas like drug discovery, genomics, and clinical diagnostics. These technological developments drive global adoption of laboratory robotics.

For instance, in May 2023, Opentrons has introduced its Opentrons Flex robot, a new era of accessible liquid-handling lab robots. Engineered for cost-effectiveness and ease of programming, this innovative Application aims to democratize advanced lab automation, making it accessible to all sizes and empowering researchers with sophisticated automation capabilities.

High Initial Investment and Maintenance Costs

The global laboratory robotics market faces significant challenges due to high initial investment and maintenance costs. Advanced Application and specialized components require significant upfront costs, making them less accessible to smaller labs and research facilities. Integration costs, such as software compatibility and infrastructure upgrades, add to the financial burden. Maintenance expenses, including servicing and calibration, further increase the total cost of ownership. The need for skilled personnel further increases operational expenses, making potential end-users, especially in developing regions, hesitate to invest in laboratory robotics.

For more details on this report - Request for Sample

Segment Analysis

The global laboratory robotics market is segmented based on product type, application, end user and region.

Product Type:

Automated Liquid Handling Systems segment is expected to dominate the Laboratory Robotics market share

The automated liquid handling systems segment holds a major portion of the laboratory robotics market share and is expected to continue to hold a significant portion of the laboratory robotics market share during the forecast period.

Automated liquid handling systems are driving the global laboratory robotics market growth by enhancing workflows, reducing human error, and increasing throughput. They are essential in high-throughput screening, genomics, proteomics, and drug discovery applications. The integration of advanced technologies like artificial intelligence and robotic arms improves their adaptability and accuracy. Automated liquid handling systems also support miniaturization of assays, reducing reagent costs and environmental waste. As laboratories prioritize efficiency, reproducibility, and scalability, demand for these systems continues to rise.

For instance, in September 2024, Opentrons Labworks has launched the Opentrons Flex Prep robot, which integrates seamlessly into laboratory workflows. The no-code software allows users to set up pipetting tasks and execute them through the Flex Prep touchscreen. The system combines the simplicity of a pipette with the power and versatility of a liquid handler, providing scientists with ease of use and enhanced capability. The touchscreen software allows users to develop, visualize, and run pipetting tasks in just a minute, offering a user-friendly experience that surpasses semi-automated solutions.

Application:-

Drug Discovery segment is the fastest-growing segment in Laboratory Robotics market share

The drug discovery segment is the fastest-growing segment in the laboratory robotics market share and is expected to hold the market share over the forecast period.

The growth in the novel drug discovery segment plays an important role in the shaping up of the global laboratory robotics market.. Especially because the pharmaceutical and the biotechnical companies are outsourcing their R & D work through these automated solutions of laboratory robotics. Mechanization of laboratory scientific processes, like robotic high throughput liquid handling devices and automated liquids high throughput techniques, facilitate advancement of the efficiency and standardization of the work. More importantly, these devices employ robotics which speeds up the work greatly and enables many more thousands to be screened.

For instance, in January 2023, Insilico Medicine, a clinical stage AI-driven drug discovery company, has launched Life Star, a 6th-generation Intelligent Robotics Drug Discovery Laboratory in Suzhou BioBAY Industrial Park. The fully automated lab performs target discovery, compound screening, precision medicine development, and translational research. It will allow Insilico to accelerate its end-to-end drug discovery and optimize the success rate of its drug development as it moves its novel therapeutics through clinical trials.

Geographical Analysis

North America is expected to hold a significant position in the Laboratory Robotics market share

North America holds a substantial position in the Laboratory Robotics market and is expected to hold most of the market share due to product launches, automation investments, and innovation in pharmaceutical and biotechnology sectors. Key market players, research institutions, and universities adopt robotic systems to improve efficiency. Government initiatives, funding, and early adoption of AI and machine learning accelerate market growth. The demand for high-throughput screening and drug discovery solutions also drives the adoption of laboratory robotics across various industries in the region.

For instance, in May 2024, Clarapath, a medical robotics company, has partnered with the Mayo Clinic to automate tissue sectioning, transfer, and quality control using robotics and AI. This collaboration aims to address labor shortages, quality control issues, and rising sample volumes, positioning the US as a leader in laboratory robotics and automation solutions.

Europe is growing at the fastest pace in the Laboratory Robotics market

Europe holds the fastest pace in the Laboratory Robotics market and is expected to hold most of the market share due to a robust healthcare infrastructure and efficient organ donation systems. Moreover, collaborations and partnerships by company's plays crucial in growth of the region. Also, Europe faces high chronic kidney disease incidence due to aging populations and lifestyle-related conditions. Advances in medical Application, such as minimally invasive surgical procedures, further fuel the market's growth.

For instance, in November 2024, Tata Elxsi, in collaboration with DENSO Robotics Europe and AAtek, has opened the 'Robotics and Automation Innovation Lab' in Frankfurt. The facility aims to drive robotics automation across sectors like medical devices, pharmaceuticals, life sciences, and food science. It will serve as a research hub for modular automation, product development, and maintenance, addressing global automation demand. Live demonstrations will showcase high-precision robotic implementations in cell/tissue culture, diagnostics, and sterilised environments.

Competitive Landscape

The major global players in the laboratory robotics market include ABB Ltd, Thermo Fisher Scientific Inc, Yaskawa Electric Corporation, KUKA AG, Festo AG & Co. KG, Universal Robots, Tecan Group Ltd, Hamilton Company, Hudson Robotics, Peak Analysis & Automation (PAA) and among others.

Key Developments

In February 2024, Opentrons Labworks, Inc., a lab automation provider and maker of accessible robotics, has launched an automation marketplace. The marketplace offers tools and software from Opentrons' partners that can be integrated into their robotics systems, catering to sectors like drug discovery and microbiome research. It functions as an eCommerce hub, allowing customers to easily access essential products, services, and support from Opentrons' commercial partners.
In January 2024, Bruker Corporation has acquired Chemspeed Technologies, a vendor-agnostic automated laboratory R&D company specializing in modular automation and robotics solutions for pharmaceutical drug formulation, thereby expanding its market reach, enhancing its R&D capabilities, and strengthening its competitiveness.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global laboratory robotics market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Initial Investment and Maintenance Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Automated Liquid Handling Systems*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Robotic Arms
6.4. Microplate Washers
6.5. Grippers
6.6. Robot-Assisted Liquid Handlers
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Drug Discovery*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Diagnostics
7.4. Genomics
7.5. Proteomics
7.6. Clinical and Research Laboratories
7.7. Chemical and Pharmaceutical Industries

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Pharmaceutical and Biotechnology Companies*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Healthcare Institutions
8.4. Academic and Research Institutions

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. ABB Ltd*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Thermo Fisher Scientific Inc.
11.3. Yaskawa Electric Corporation
11.4. KUKA AG
11.5. Festo AG & Co. KG
11.6. Universal Robots
11.7. Tecan Group Ltd.
11.8. Hamilton Company
11.9. Hudson Robotics
11.10. Peak Analysis & Automation (PAA)

LIST NOT EXHAUSTIVE